Susan Serrano
Sr. Director, Market Access Intellia Therapeutics
Seminars
Thursday 26th March 2026
Starting With the End in Mind to Optimize Gene Therapy Development for Long-Term Impact
9:30 am
- Designing clinical trials and programs with commercialization and patient access in mind from the start
- Defining the right target patient and unmet need to build a strong, scalable value proposition
- Making early trial decisions on dosing, administration, and monitoring to optimize provider and payer adoption
